167 related articles for article (PubMed ID: 17633952)
1. The prevention, diagnosis, referral and management of melanoma of the skin: concise guidelines.
Bishop JN; Bataille V; Gavin A; Lens M; Marsden J; Mathews T; Wheelhouse C
Clin Med (Lond); 2007 Jun; 7(3):283-90. PubMed ID: 17633952
[TBL] [Abstract][Full Text] [Related]
2. The transformation rate of moles (melanocytic nevi) into cutaneous melanoma: a population-based estimate.
Tsao H; Bevona C; Goggins W; Quinn T
Arch Dermatol; 2003 Mar; 139(3):282-8. PubMed ID: 12622618
[TBL] [Abstract][Full Text] [Related]
3. High naevus count and MC1R red hair alleles contribute synergistically to increased melanoma risk.
Duffy DL; Lee KJ; Jagirdar K; Pflugfelder A; Stark MS; McMeniman EK; Soyer HP; Sturm RA
Br J Dermatol; 2019 Nov; 181(5):1009-1016. PubMed ID: 30820946
[TBL] [Abstract][Full Text] [Related]
4. [Melanocytic nevi as one of the risk factors of melanoma malignum].
Małaczewska J; Dabkowski J
Pol Merkur Lekarski; 2004 Mar; 16(93):298-302. PubMed ID: 15190614
[TBL] [Abstract][Full Text] [Related]
5. Association of Patient Risk Factors and Frequency of Nevus-Associated Cutaneous Melanomas.
Haenssle HA; Mograby N; Ngassa A; Buhl T; Emmert S; Schön MP; Rosenberger A; Bertsch HP
JAMA Dermatol; 2016 Mar; 152(3):291-8. PubMed ID: 26536613
[TBL] [Abstract][Full Text] [Related]
6. Melanoma detection rate and concordance between self-skin examination and clinical evaluation in patients attending a pigmented lesion clinic in Italy.
Carli P; De Giorgi V; Nardini P; Mannone F; Palli D; Giannotti B
Br J Dermatol; 2002 Feb; 146(2):261-6. PubMed ID: 11903237
[TBL] [Abstract][Full Text] [Related]
7. The MOLES system to guide the management of melanocytic choroidal tumours: can optometrists apply it?
Flanagan JP; O'Day RF; Roelofs KA; McGuinness MB; van Wijngaarden P; Damato BE
Clin Exp Optom; 2023 Apr; 106(3):271-275. PubMed ID: 35156536
[TBL] [Abstract][Full Text] [Related]
8. Clinical and Histopathologic Characteristics of Melanocytic Lesions on the Volar Skin Without Typical Dermoscopic Patterns.
Mikoshiba Y; Minagawa A; Koga H; Yokokawa Y; Uhara H; Okuyama R
JAMA Dermatol; 2019 May; 155(5):578-584. PubMed ID: 30865233
[TBL] [Abstract][Full Text] [Related]
9. Melanocytic dysplastic naevi occupy the middle ground between benign melanocytic naevi and cutaneous malignant melanomas: emerging clues.
Hussein MR
J Clin Pathol; 2005 May; 58(5):453-6. PubMed ID: 15858113
[TBL] [Abstract][Full Text] [Related]
10. [Not diagnosable malignant melanomas].
Neuber H; Lippold A; Hundeiker M
Hautarzt; 1991 Apr; 42(4):220-2. PubMed ID: 1860796
[TBL] [Abstract][Full Text] [Related]
11. Histologic mimics of malignant melanoma.
Bsirini C; Smoller BR
Singapore Med J; 2018 Nov; 59(11):602-607. PubMed ID: 29774360
[TBL] [Abstract][Full Text] [Related]
12. Relationship between cause of referral and diagnostic outcome in pigmented lesion clinics: a multicentre survey of the Italian Multidisciplinary Group on Melanoma (GIPMe).
Carli P; De Giorgi V; Betti R; Vergani R; Catricala C; Mariani G; Simonacci M; Bettacchi A; Bottoni U; Lo Scocco G; Mulas P; Giannotti B
Melanoma Res; 2003 Apr; 13(2):207-11. PubMed ID: 12690308
[TBL] [Abstract][Full Text] [Related]
13. Malignant melanomas masquerade--as benign naevi.
Burge TS
J R Army Med Corps; 1992 Feb; 138(1):38-9. PubMed ID: 1578433
[TBL] [Abstract][Full Text] [Related]
14. Neck Melanoma: Clinical, Dermoscopic and Confocal Features.
Borsari S; Pampena R; Raucci M; Mirra M; Piana S; Pellacani G; Longo C
Dermatology; 2020; 236(3):241-247. PubMed ID: 31707398
[TBL] [Abstract][Full Text] [Related]
15. Distribution and colocalization of markers for proliferation, invasion, motility and neoangiogenesis in benign melanocytic naevi and malignant melanomas.
Fröhlich E; Mack AF; Garbe C; Klessen C
Br J Dermatol; 2005 Dec; 153(6):1159-65. PubMed ID: 16307652
[TBL] [Abstract][Full Text] [Related]
16. Atypical mole syndrome: risk factor for cutaneous malignant melanoma and implications for management.
Slade J; Marghoob AA; Salopek TG; Rigel DS; Kopf AW; Bart RS
J Am Acad Dermatol; 1995 Mar; 32(3):479-94. PubMed ID: 7868720
[TBL] [Abstract][Full Text] [Related]
17. Melanocytic naevus or malignant melanoma? A large-scale epidemiological study of diagnostic accuracy.
Lindelöf B; Hedblad MA; Sigurgeirsson B
Acta Derm Venereol; 1998 Jul; 78(4):284-8. PubMed ID: 9689297
[TBL] [Abstract][Full Text] [Related]
18. Elevated non-coding promoter mutations are associated with malignant transformation of melanocytic naevi to melanoma.
Colebatch AJ; Paver EC; Vergara IA; Thompson JF; Long GV; Wilmott JS; Scolyer RA
Pathology; 2022 Aug; 54(5):533-540. PubMed ID: 35248370
[TBL] [Abstract][Full Text] [Related]
19. Intermediate-effect biomarkers in prevention of skin cancer.
Doré JF; Pedeux R; Boniol M; Chignol MC; Autier P
IARC Sci Publ; 2001; 154():81-91. PubMed ID: 11220671
[TBL] [Abstract][Full Text] [Related]
20. Paediatric melanoma.
Wood BA
Pathology; 2016 Feb; 48(2):155-65. PubMed ID: 27020388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
